This HTML5 document contains 26 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/domain/vavai/cep/soutez/
n9http://linked.opendata.cz/resource/domain/vavai/cep/kategorie/
dctermshttp://purl.org/dc/terms/
n2http://linked.opendata.cz/resource/domain/vavai/cep/projekt/MSM/
n13http://linked.opendata.cz/resource/domain/vavai/cep/aktivita/
n4http://linked.opendata.cz/ontology/domain/vavai/
n6http://linked.opendata.cz/resource/domain/vavai/cep/obor/
n5http://linked.opendata.cz/resource/domain/vavai/cep/druh-souteze/
n7http://linked.opendata.cz/resource/domain/vavai/cep/smlouva/3094/
n11http://linked.opendata.cz/resource/domain/vavai/cep/faze/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/domain/vavai/cep/typ/
n10http://linked.opendata.cz/resource/domain/vavai/cep/poskytovatel/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:7E08043
rdf:type
n4:Projekt
dcterms:description
Direct vaccination cannot prevent diseases that affect neonates in the first days of live. Group B Streptococcus (GBS) is the major cause of neonatal septicemia nd meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that high titres of maternal antibody to GBS capsular polysaccharides (CPS) correlate with reduced risk of diseases in neonates suggesting that maternal immunization may be an effective strategy for delivery of a protective immune response to the child in this early period. The overall objective of this proposal is to design immunization strategies capable of inducing strong durable and placentally transferable protective immune responses agains GBS in women in order to fill this gap in early infancy when direct immunization is not possible.Starting with the genome sequenceof 8 strains of GBS, Novartis scientist Direct vaccination cannot prevent diseases that affect neonates in the first days of live. Group B Streptococcus (GBS) is the major cause of neonatal septicemia nd meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that high titres of maternal antibody to GBS capsular polysaccharides (CPS) correlate with reduced risk of diseases in neonates suggesting that maternal immunization may be an effective strategy for delivery of a protective immune response to the child in this early period. The overall objective of this proposal is to design immunization strategies capable of inducing strong durable and placentally transferable protective immune responses agains GBS in women in order to fill this gap in early infancy when direct immunization is not possible.Starting with the genome sequenceof 8 strains of GBS, Novartis scientist
dcterms:title
Desing of a vaccine to immunize neonates against GBS infections through a durable maternal immune response Desing of a vaccine to immunize neonates against GBS infections through a durable maternal immune response
n4:cislo-smlouvy
n7:2010-32
n4:dalsi-vedlejsi-obor
n6:EC
n4:druh-souteze
n5:RP
n4:faze
n11:53237428
n4:hlavni-obor
n6:FN
n4:vedlejsi-obor
n6:EE
n4:id-aktivity
n13:7E
n4:id-souteze
n12:
n4:kategorie
n9:2
n4:klicova-slova
Vaccine; GBS; Streptococcos; Newborns; Passive immunisations
n4:konec-reseni
2010-12-31+01:00
n4:pocet-koordinujicich-prijemcu
0
n4:poskytovatel
n10:MSM
n4:start-reseni
2008-01-01+01:00
n4:statni-podpora
2508
n4:typProjektu
n8:P
n4:uznane-naklady
2508
n4:pocet-prijemcu
1
n4:pocet-spoluprijemcu
0
n4:pocet-vysledku
2
n4:pocet-vysledku-zverejnovanych
2